Grup B Streptokok İnfeksiyonları

47.Jackson LA, Hildson R, Farley M, et al. Risk factors for group B
streptococcal disease in adults. Ann Intern Med 1995;123:415-20.
48.Marques MB, Kasper DL, Pangburn MK, et al. Prevention of C3
deposition by capsular polysaccharide is a virulence mechanism of type III
group B streptococci. Infect Immun 1992;14:3986-93.
49.Nizet V, Gibson R, Chi E, et al. Group B streptococcal beta-hemolysin
expression is associated with injury of lung epithelial cells. Infect Immun
1996;64:3818-26.
50.Hickman ME, Rench MA, Ferrieri P, et al. Changing epidemiology of
group B streptococcal colonization. Pediatrics !999;104:203-9.
51.Garcia BM, Harper MB, Fleisher GR. Occult bacteremia with group B
streptococci in an outpatient setting. Pediatrics. 1998;102:67-72.
52.Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissue. N
Engl J Med 1996;334:240-5.
53.Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B
streptococcal infection in adults: results from a Canadian, population-based,
active laboratory surveillance study-1996. J Infect Dis 2000;182:168-73.
54.Mertz KR, Baddour LM, Bell JL. Breast cellulitis following breast
conservation therapy: A novel complication of medical progress. Clin Infect
Dis 1998;26:481-6.
55.Domingo P, Barquet N, Alvarez M, et al. Group B streptococcal meningitis
in adults: Report of twelve cases and review. Clin Infect Dis 1997;25:1180-7.
56.Sambola A, Miro JM, Tornos P, et al. Streptococcus agalactiae infective
endocarditis: Analysis of 30 cases and review of the literature, 1962-1998.
Clin Infect Dis 2002;34:1576-84.
57.Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of
group B streptococci isolated between 1992 and 1996 from patients with
bacteremia and meningitis. Antimicrob Agents Chemother 1998;42:1517-9.
57.Lin FY, Azimi PH, Weisman LE, et al. Antibiotic susceptibility profiles for
group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis
2000;1:76-9.
45